What do systematic reviews say?

Summary of findings for all doses of nasal decongestant vs placebo

The review found no eligible studies for this question.

• Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings for single‐dose nasal decongestant vs placebo

• Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 82 participants
  GRADE not reported

Summary of findings for multi‐dose nasal decongestant vs placebo

Summary of findings for multi‐dose nasal decongestant showed no clear difference in secondary outcome: all adverse events compared with placebo (low certainty).

• Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
  OR 0.98 [0.68, 1.4]
  7 studies · 1195 participants
  Low

Summary of findings for multi‐dose nasal decongestant vs placebo

Summary of findings for multi‐dose nasal decongestant showed no clear difference in secondary outcome: all adverse eventsOral compared with placebo (low certainty).

• Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
  OR 0.95 [0.65, 1.39]
  6 studies · 1134 participants
  Low

Summary of findings for multi‐dose nasal decongestant vs placebo

• Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 61 participants
  GRADE not reported